A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility

Oncogene

Volumn 30, Issue 44, 2011, Pages 4464-4475

  Leung, W K C ^a,b   Ching, A K K ^a,b   Chan, A W H ^a   Poon, T C W ^b   Mian, H ^a,b   Wong, A S T ^c   To, K F ^a,b   Wong, N ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

actin; cell migration; hepatocellular carcinoma; PFTK1; TAGLN2

Indexed keywords

ACTIN; BETA ACTIN; CYCLIN DEPENDENT KINASE 1; SERINE; TRANSGELIN 2; TYROSINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GRADING; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; DEPOLYMERIZATION; FEMALE; HUMAN; HUMAN CELL; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONSET AGE; PFTK1 GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; TAGLN2 GENE; TUMOR SUPPRESSOR GENE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACTINS; ADULT; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIN-DEPENDENT KINASES; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; MALE; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; PHOSPHORYLATION; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80455174794     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.161     Document Type: Article

References (28)

1. Assinder SJ, Stanton JA, Prasad PD. (2009). Transgelin: an actin-binding protein and tumour suppressor. Int J Biochem Cell Biol 41: 482-486.
2. Baek K, Liu X, Ferron F, Shu S, Korn ED, Dominguez R. (2008). Modulation of actin structure and function by phosphorylation of Tyr-53 and profilin binding. Proc Natl Acad Sci USA 105: 11748-11753.
3. Fu Y, Liu HW, Forsythe SM, Kogut P, McConville JF, Halayko AJ et al. (2000). Mutagenesis analysis of human SM22: characterization of actin binding. J Appl Physiol 89: 1985-1990.
4. Herath NI, Leggett BA, MacDonald GA. (2006). Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastroenterol Hepatol 21: 15-21.
5. Katoh H, Ojima H, Kokubu A, Saito S, Kondo T, Kosuge T et al. (2007). Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. Gastroenter-ology 133: 1475-1486. (Pubitemid 350029748)
6. Kirschner M. (1992). The cell cycle then and now. Trends Biochem Sci 17: 281-285.
7. Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O et al. (1998). DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 152: 1107-1123. (Pubitemid 28221862)
8. Kubota H, Mikhailenko SV, Okabe H, Taguchi H, Ishiwata S. (2009). D-loop of actin differently regulates the motor function of myosins II and V. J Biol Chem 284: 35251-35258.
9. Manes T, Zheng DQ, Tognin S, Woodard AS, Marchisio PC, Languino LR. (2003). avb3 integrin expression up-regulates cdc2, which modulates cell migration. J Cell Biol 161: 817-826. (Pubitemid 36648764)
10. Nair RR, Solway J, Boyd DD. (2006). Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem 281: 26424-26436. (Pubitemid 44401851)
11. Nakao K, Shibussawa M, Ishihara A, Yoshizawa H, Tsunoda A, Kusano M et al. (2001). Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy. Cancer 91: 721-726. (Pubitemid 32173296)
12. Neumeister P, Pixley FJ, Xiong Y, Xie H, Wu K, Ashton A et al. (2003). Cyclin D1 governs adhesion and motility of macrophages. Mol Biol Cell 14: 2005-2015. (Pubitemid 36583549)
13. Pang E, Wong N, Lai PB, To KF, Lau WY, Johnson PJ. (2002). Consistent chromosome 10 rearrangements in four newly established human hepato-cellular carcinoma cell lines. Genes Chromosomes Cancer 33: 150-159. (Pubitemid 34052496)
14. Pang EY, Bai AH, To KF, Sy SM, Wong NL, Lai PB et al. (2007). Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells. Hepatology 46: 436-445. (Pubitemid 47344779)
15. Pines J. (1992). Cell proliferation and control. Curr Opin Cell Biol 4: 144-148.
16. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. (1999). Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229: 216-222. (Pubitemid 30191795)
17. Poon TC, Wong N, Lai PB, Rattray M, Johnson PJ, Sung JJ. (2006). A tumor progression model for hepatocellular carcinoma: bioinfor-matic analysis of genomic data. Gastroenterology 131: 1262-1270. (Pubitemid 44515104)
18. Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ et al. (2005). Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23: 94-101. (Pubitemid 41724631)
19. Shields JM, Rogers-Graham K, Der CJ. (2002). Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J Biol Chem 277: 9790-9799. (Pubitemid 34968082)
20. Solomon MJ. (1993). Activation of the various cyclin/cdc2 protein kinases. Curr Opin Cell Biol 5: 180-186.
21. Strohmeyer DM, Berger AP, Moore II DH, Bartsch G, Klocker H, Carroll PR et al. (2004). Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Prostate 59: 43-58. (Pubitemid 38387842)
22. Vincent-Salomon A, Thiery JP. (2003). Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 5: 101-106. (Pubitemid 36348104)
23. Wong N, Yeo W, Wong WL, Wong NL, Chan KY, Mo FK et al. (2009). TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemore-sistance. Int J Cancer 124: 644-652.
24. Wulfkuhle JD, Sgroi DC, Krutzsch H, McLean K, McGarvey K, Knowlton M et al. (2002). Proteomics of human breast ductal carcinoma in situ. Cancer Res 62: 6740-6749. (Pubitemid 35364146)
25. Xu SG, Yan PJ, Shao ZM. (2010). Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. J Cancer Res Clin Oncol 136: 1545-1556.
26. Yang T, Chen JY. (2001). Identification and cellular localization of PFTAIRE1. Gene 267: 165-172.
27. Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y, Chen Z et al. (2007). Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth. Mol Endocrinol 21: 343-358. (Pubitemid 46184889)
28. Zhao L, Wang H, Deng YJ, Wang S, Liu C, Jin H et al. (2009). Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients. Mod Pathol 22: 786-796.